📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Syntimmune

1.1 - Company Overview

Syntimmune Logo

Syntimmune

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage biotechnology drug candidates for a wide range of autoimmune diseases, advancing differentiated therapies based on expertise in neonatal Fc receptor (FcRn) biology and its role in the pathogenesis of IgG-mediated conditions.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Syntimmune

Relief Therapeutics Logo

Relief Therapeutics

HQ: Switzerland Website
  • Description: Provider of clinical-stage biotechnological therapies based on molecules of natural origin (peptides and proteins), focusing on respiratory disease indications. Portfolio includes RLF-100 (Aviptadil) for acute and chronic lung diseases; Sentinox nasal spray; RLF-TD011 and Nexodyn AOS hypochlorous acid wound solutions; PKU GOLIKE for phenylketonuria; OLPRUVA for urea cycle disorders.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Relief Therapeutics company profile →
InDex Pharmaceuticals Logo

InDex Pharmaceuticals

HQ: Sweden Website
  • Description: Provider of clinical-stage biopharmaceutical immunotherapy R&D based on a toll-like receptor (TLR) platform, discovering and developing DNA-based immunomodulatory sequence (DIMS) drugs to treat diseases in therapeutic areas including inflammation and cancer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full InDex Pharmaceuticals company profile →
Medannex Logo

Medannex

HQ: United Kingdom Website
  • Description: Provider of biopharmaceutical solutions targeting annexin-A1, notably MDX-124—a humanised monoclonal antibody with potential in treating various cancers and autoimmune diseases—and the ATTAINMENT Phase 1b clinical study evaluating the safety, tolerability, and efficacy of MDX-124 in solid malignancies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Medannex company profile →
Abgenix Logo

Abgenix

HQ: United States Website
  • Description: Provider of human therapeutic antibody discovery, development, and manufacturing for treating diseases such as cancer, inflammation, and metabolic disease. Pipeline includes antibody therapeutic product candidates in clinical trials, including Panitumumab (ABX-EGF).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Abgenix company profile →
Frame Therapeutics Logo

Frame Therapeutics

HQ: The Netherlands Website
  • Description: Provider of DNA-based cancer vaccines tailored to the unique characteristics of each patient's tumor, aiming to transform cancer treatment by directing the immune system toward Frame neoantigens.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Frame Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Syntimmune

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Syntimmune

2.2 - Growth funds investing in similar companies to Syntimmune

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Syntimmune

4.2 - Public trading comparable groups for Syntimmune

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Syntimmune

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Syntimmune

What does Syntimmune do?

Syntimmune is a provider of clinical-stage biotechnology drug candidates for a wide range of autoimmune diseases, advancing differentiated therapies based on expertise in neonatal Fc receptor (FcRn) biology and its role in the pathogenesis of IgG-mediated conditions.

Who are Syntimmune's competitors?

Syntimmune's competitors and similar companies include Relief Therapeutics, InDex Pharmaceuticals, Medannex, Abgenix, and Frame Therapeutics.

Where is Syntimmune headquartered?

Syntimmune is headquartered in United States.

How many employees does Syntimmune have?

Syntimmune has 1,000 employees 🔒.

When was Syntimmune founded?

Syntimmune was founded in 2010 🔒.

What sector and industry vertical is Syntimmune in?

Syntimmune is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Syntimmune

Who are the top strategic acquirers in Syntimmune's sector and industry

Top strategic M&A buyers and acquirers in Syntimmune's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Syntimmune?

Top strategic M&A buyers groups and sectors for Syntimmune include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Syntimmune's sector and industry vertical

Which are the top PE firms investing in Syntimmune's sector and industry vertical?

Top PE firms investing in Syntimmune's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Syntimmune's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Syntimmune's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Syntimmune's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Syntimmune include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Syntimmune's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Syntimmune?

The key public trading comparables and valuation benchmarks for Syntimmune include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Syntimmune for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Syntimmune with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Syntimmune's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Syntimmune with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Syntimmune's' sector and industry vertical?

Access recent funding rounds and capital raises in Syntimmune's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Syntimmune